Kameda Seika

Kameda Seika is a prominent Japanese corporation that, while traditionally known as a leader in the rice cracker market, has established a significant presence in the life sciences and healthcare sectors. The company operates a dedicated Rice Research Institute focusing on the functional properties of rice and plant-based lactic acid bacteria. Their healthcare portfolio includes proprietary probiotic strains like Lactobacillus K-1 and K-2, which are clinically studied for digestive health and immune modulation. Furthermore, Kameda Seika is a key provider of medical nutrition products, specifically low-protein rice for individuals with chronic kidney disease. The company leverages its expertise in fermentation and rice chemistry to develop value-added ingredients for the global functional food and supplement industries. Through its Better For You strategy, Kameda Seika continues to expand its clinical research into the systemic health benefits of rice-derived components.